For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3a, 7ß-2-hydroxy-5ß-bile acid, UDCA) was first found in the bile of a black bear.
Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.
Scope of the Report:
This report focuses on the Ursodeoxycholic Acid in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Ursodeoxycholic Acid used to treat liver disease. Ursodeoxycholic Acid has positive effects on treatment of liver disease. The classification of Ursodeoxycholic Acid includes Synthetic Ursodeoxycholic Acid and Extraction Ursodeoxycholic Acid. The proportion of Synthetic Ursodeoxycholic Acid in 2017 is about 73.4%, and the proportion of Extraction Ursodeoxycholic Acid in 2017 is about 26.57%.
Ursodeoxycholic Acid is application in Pharmacy and Health Products. The most of Ursodeoxycholic Acid is used in Health Products, and the market share in 2017 is about 69.2%.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 47% in 2017. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of 26.6% in 2017.
In China, about major production is for export. Asia is the main consumption regions. Japan and South Korea are the major consumer countries.
In the Asian region due to the traditional reasons ursodeoxycholic acid is mainly used as healthcare industry.
Europe is the main supplier of Ursodeoxycholic Acid, with production revenue market share over 41%, while the sales market share is 26.4% in 2017. That is to say, there are a number of exports in Europe. Asia is also the main supplier of Ursodeoxycholic Acid, with production revenue market share over 42%, while the sales market share is 47% in 2017.
Market competition is intense. With the development of society and the changing of consumer demand, the Ursodeoxycholic Acid industry will be more and more popular in the future.
The worldwide market for Ursodeoxycholic Acid is expected to grow at a CAGR of roughly 10.4% over the next five years, will reach 960 million US$ in 2023, from 530 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Mitsubishi Tanabe Pharma
- Daewoong Chemical
- PharmaZell GmbH
- Dipharma Francis
- Abil Chempharma
- Biotavia Labs
- Suzhou Tianlu
- Arcelor Chemicals
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Synthetic UDCA
- Extraction UDCA
Market Segment by Applications, can be divided into
- Health Products
There are 15 Chapters to deeply display the global Ursodeoxycholic Acid market.
Chapter 1, to describe Ursodeoxycholic Acid Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Ursodeoxycholic Acid, with sales, revenue, and price of Ursodeoxycholic Acid, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Ursodeoxycholic Acid, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Ursodeoxycholic Acid market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Ursodeoxycholic Acid sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source